Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age. Subjects will answer the following questionnaire and tests: * Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS) * Demographic Questionnaire - composed by the researchers * Family Eating Habits Questionnaire (FEAHQ-33) * Food Frequency Questionnaire (FFQ) * Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
45
Reduce symptoms of attention deficit measured by MOXO test
After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test
Time frame: Six month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.